Benjamin Greenbaum, PhD, is a new Associate Attending in the Computational Oncology Service. Dr. Greenbaum’s research seeks to quantify the interaction of tumors with the immune system and to predict immune driven evolution of tumors and viruses. His work utilizes a broad range of tools, from statistical physics and information theory to evolutionary biology. As part of his new role, he will establish a new program in Computational Immuno-Oncology. This program will bring computational approaches to immunotherapy and act as a bridge between the Computational Oncology Service and the Parker Institute for Cancer Immunotherapy, a collaboration of six academic centers including MSK with the goal to use the power of the immune system to fight cancer. Dr. Greenbaum has a PhD in theoretical physics from Columbia University and has trained at Los Alamos National Laboratory and the Institute for Advanced Study. He previously held the role of Associate Professor at Icahn School of Medicine at Mount Sinai in the Departments of Medicine and Oncological Sciences, where he was the founding director of the Center for Computational Immunology. Dr. Greenbaum authored many publications in high-ranking journals and holds several awards including a Phillip A. Sharp Award for Innovation in Collaboration from Stand Up to Cancer, a Pershing Square Sohn Prize, and a Mark Foundation Fellowship.